SEMA3A inhibitors belong to a chemical class designed to interact with and modulate the activity of SEMA3A, which is a secreted protein belonging to the semaphorin family. SEMA3A plays a critical role in various biological processes, particularly in axon guidance and neural development. It functions as a repulsive guidance cue, helping to guide developing axons by regulating their growth and pathfinding. By binding to its receptors on the surface of growth cones, SEMA3A provides crucial cues that steer axons away from inappropriate areas, ensuring accurate neural circuit formation.
Inhibiting SEMA3A involves disrupting its interactions with its receptors, thereby affecting the guidance cues provided to growing axons. By exploring the effects of SEMA3A inhibitors, researchers aim to gain deeper insights into the complex molecular mechanisms that underlie neural development and axon guidance. This research contributes to our understanding of how neural circuits are formed during development and how abnormalities in these processes can lead to neurological disorders. Additionally, the study of SEMA3A inhibitors sheds light on the broader role of semaphorin family proteins in various biological contexts beyond neural development, unveiling applications in different fields of biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $153.00 $938.00 | 5 | |
Tyrosine kinase inhibitor affecting RTKs involved in SEMA3A pathways. | ||||||
2-Methoxyestradiol | 362-07-2 | sc-201371 sc-201371A | 10 mg 50 mg | $71.00 $288.00 | 6 | |
Endogenous metabolite that may inhibit SEMA3A-induced angiogenesis by affecting downstream pathways. | ||||||
VEGFR2 Kinase Inhibitor I | 15966-93-5 | sc-202850 | 1 mg | $150.00 | 1 | |
Inhibits FGFR tyrosine kinases, which might intersect with SEMA3A signaling. | ||||||
AZD1480 | 935666-88-9 | sc-364735 sc-364735A | 5 mg 50 mg | $124.00 $1072.00 | 11 | |
JAK2 inhibitor that may modulate SEMA3A signaling through downstream effects on related pathways. | ||||||
Ulixertinib | 869886-67-9 | sc-507296 | 10 mg | $176.00 | ||
Reversible inhibitor of ERK1/2, downstream of SEMA3A pathways, potentially affecting SEMA3A effects. | ||||||
BIBF1120 | 656247-17-5 | sc-364433 sc-364433A | 5 mg 10 mg | $184.00 $321.00 | 2 | |
Multitarget tyrosine kinase inhibitor affecting RTKs, indirectly influencing SEMA3A-related processes. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Multikinase inhibitor targeting various RTKs, potentially affecting SEMA3A signaling. | ||||||
Dovitinib, Free Base | 405169-16-6 | sc-396771 sc-396771A | 10 mg 25 mg | $170.00 $350.00 | ||
Pan-RTK inhibitor impacting SEMA3A-related processes through its effects on RTKs. | ||||||
Pazopanib Hydrochloride | 635702-64-6 | sc-364564 sc-364564A | 10 mg 25 mg | $107.00 $230.00 | 1 | |
Multitarget tyrosine kinase inhibitor potentially influencing SEMA3A pathways via RTK inhibition. | ||||||
Tivozanib | 475108-18-0 | sc-475339 | 5 mg | $320.00 | ||
Tyrosine kinase inhibitor potentially affecting SEMA3A signaling through inhibitory effects on RTKs. | ||||||